Shanghai Junshi Biosciences Co., Ltd. (SHJBF)
USD 1.24
(0.0%)
USD 1.24
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.5 Billion | 1.45 Billion | 4.02 Billion | 1.59 Billion | 775.08 Million | 934 Thousand |
| Cost of Revenue | 667.29 Million | 526.28 Million | 1.25 Billion | 372.53 Million | 90.68 Million | 267 Thousand |
| Gross Profit | 835.26 Million | 927.21 Million | 2.76 Billion | 1.22 Billion | 684.4 Million | 667 Thousand |
| Operating Expenses | 3.28 Billion | 3.64 Billion | 3.35 Billion | 2.89 Billion | 1.45 Billion | 678.69 Million |
| Selling, General and Administrative Expenses | 1.4 Billion | 1.29 Billion | 1.38 Billion | 1.13 Billion | 536.94 Million | 145.14 Million |
| Research and Development Expenses | 1.93 Billion | 2.38 Billion | 2.06 Billion | 1.77 Billion | 946.1 Million | 538.18 Million |
| Other Expenses | -11 Million | 5.03 Million | -35.2 Million | -19.68 Million | -21.77 Million | 10.92 Million |
| Cost and Expenses | 3.95 Billion | 4.17 Billion | 4.61 Billion | 3.26 Billion | 1.54 Billion | 678.96 Million |
| Operating Income | -2.45 Billion | -409.07 Million | -104.93 Million | -245.73 Million | -117.25 Million | -104.66 Million |
| Interest Expense | 29 Million | 29.37 Million | 21.83 Million | 29.39 Million | 13.3 Million | 2.08 Million |
| Income Tax Expense | 43.99 Million | -93.1 Million | 135.53 Million | -3.82 Million | -18.89 Million | -1.21 Million |
| Earnings before Tax | -2.48 Billion | -2.67 Billion | -592.64 Million | -1.66 Billion | -763.12 Million | -717.71 Million |
| Net Income | -2.28 Billion | -2.38 Billion | -718.55 Million | -1.66 Billion | -743.92 Million | -716.41 Million |
| Earnings Per Share Basic | -2.32 | -2.60 | -0.81 | -2.02 | -0.95 | -1.19 |
| Earnings Per Share Diluted | -2.32 | -2.60 | -0.80 | -2.02 | -0.95 | -1.19 |
| Weighted Average Shares Outstanding | 984.23 Million | 917.46 Million | 890.01 Million | 824.81 Million | 783.62 Million | 601.91 Million |
| Weighted Average Shares Outstanding (Diluted) | 984.23 Million | 917.46 Million | 892.65 Million | 824.81 Million | 783.62 Million | 601.91 Million |
| Gross Margin | 0.56 | 0.64 | 0.69 | 0.77 | 0.88 | 0.71 |
| EBIT Margin | -1.44 | -1.64 | -0.11 | -0.96 | -0.91 | -695.16 |
| Profit Margin | -1.52 | -1.64 | -0.18 | -1.04 | -0.96 | -767.04 |
| EBITDA | -2.15 Billion | -2.35 Billion | -308.25 Million | -1.48 Billion | -690.23 Million | -685.42 Million |
| Earnings Before Tax Margin | -1.64 | -0.28 | -0.03 | -0.15 | -0.15 | -112.06 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 67.12 Million | 405.25 Million | 52.14 Million | 1.5 Billion | 70.56 Million | -669.7 Million |
| Cost of Revenue | 16.08 Million | 102.7 Million | 15.02 Million | 667.29 Million | 36.71 Million | 11.67 Million |
| Gross Profit | 51.03 Million | 302.54 Million | 37.11 Million | 835.26 Million | 33.84 Million | -681.37 Million |
| Operating Expenses | 97.96 Million | 625.22 Million | 80.91 Million | 3.28 Billion | 164.15 Million | -17.33 Million |
| Selling, General and Administrative Expenses | 53.69 Million | 488.56 Million | 43.39 Million | - | 63.44 Million | 298.71 Million |
| Research and Development Expenses | 45.88 Million | 270.08 Million | 38.4 Million | - | 88.1 Million | 322.02 Million |
| Other Expenses | 1.61 Million | -5.39 Million | 878.24 Thousand | -35.84 Million | -12.6 Million | -11.43 Million |
| Cost and Expenses | 114.04 Million | 727.93 Million | 95.93 Million | 3.95 Billion | 200.87 Million | -305.85 Million |
| Operating Income | -46.92 Million | -322.38 Million | -43.79 Million | -2.47 Billion | -130.31 Million | -55.39 Million |
| Interest Expense | 1.71 Million | 12.7 Million | 11.68 Million | 29 Million | - | 1 Million |
| Income Tax Expense | 74.23 Thousand | 452.4 Thousand | 430.66 Thousand | 43.99 Million | 13.33 Million | -1.89 Million |
| Earnings before Tax | -42.58 Million | -388.34 Million | -40.19 Million | -2.48 Billion | -120.79 Million | -431.68 Million |
| Net Income | -39.43 Million | -362.66 Million | -39.33 Million | -2.28 Billion | -121.32 Million | -410.39 Million |
| Earnings Per Share Basic | -0.04 | -0.37 | -0.04 | - | -0.12 | -0.42 |
| Earnings Per Share Diluted | -0.04 | -0.37 | -0.04 | - | -0.12 | -0.42 |
| Weighted Average Shares Outstanding | 984.87 Million | 985.01 Million | 985.01 Million | 984.23 Million | 985.01 Million | 985.68 Million |
| Weighted Average Shares Outstanding (Diluted) | 984.87 Million | 985.01 Million | 985.01 Million | 984.23 Million | 985.01 Million | 985.68 Million |
| Gross Margin | 0.76 | 0.75 | 0.71 | 0.56 | 0.48 | 1.02 |
| EBIT Margin | -0.61 | -0.80 | -6.07 | - | -1.68 | 0.43 |
| Profit Margin | -0.59 | -0.89 | -0.75 | -1.52 | -1.72 | 0.61 |
| EBITDA | -40.87 Million | -322.38 Million | -316.44 Million | - | -118.23 Million | -291.31 Million |
| Earnings Before Tax Margin | -0.70 | -0.80 | -0.84 | -1.65 | -1.85 | 0.08 |
019170
LSRCF
SINGER
1317
NIITMTS
GLMD